openPR Logo
Press release

U.S. Ketamine Clinics Market Size, Growing Demand, Trends Analysis and Forecast Report 2023-2028

11-17-2023 07:36 AM CET | Health & Medicine

Press release from: IMARC Group

U.S. Ketamine Clinics Market

U.S. Ketamine Clinics Market

According to IMARC Group's latest research report, titled "U.S. Ketamine Clinics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," offers a comprehensive analysis of the industry, which comprises insights on the U.S. ketamine clinics market. The report also includes competitor and regional analysis, and contemporary advancements in the market.

How Big Is the U.S. Ketamine Clinics Market?

The U.S. ketamine clinics market size reached US$ 3.24 Billion in 2022 and is expected to reach US$ 5.91 Billion by 2028, exhibiting a growth rate (CAGR) of 10.60% during 2023-2028.

Request for a PDF sample of this report: https://www.imarcgroup.com/us-ketamine-clinics-market/requestsample

What is Ketamine Clinics?

Ketamine clinics are medical facilities that specialize in the administration of ketamine, which is a powerful anesthetic and analgesic medication. These clinics are known for their use of ketamine in the treatment of various mental health conditions, such as depression, anxiety, and post-traumatic stress disorder (PTSD). At a ketamine clinic, trained medical professionals carefully administer ketamine through intravenous (IV), intramuscular (IM), or nasal spray routes, typically in low doses. The treatment is often referred to as ketamine therapy or infusion therapy, which is used off-label for mental health conditions when other treatments have proven ineffective. Moreover, ketamine clinics help individuals feel relief through ketamine therapy who have not responded to traditional antidepressants. As ketamine clinics prioritize patient safety, monitoring, and a controlled environment to minimize potential side effects and ensure a positive experience, their demand is rising in the US.

Read Full Report: https://www.imarcgroup.com/us-ketamine-clinics-market

U.S. Ketamine Clinics Market Trends and Drivers:

The increasing prevalence of mental health conditions like depression, anxiety, and post-traumatic stress disorder (PTSD) is creating a substantial demand for innovative treatments in the US. Ketamine is showing rapid and often effective results in treating these conditions, driving patients and healthcare providers to explore its potential. In addition, ketamine offers hope for individuals with treatment-resistant depression, leading them to seek out specialized ketamine clinics for alternative solutions in the US. Besides this, the increasing awareness about the benefits of ketamine therapy is encouraging more patients to seek this treatment option. Word-of-mouth recommendations, testimonials, and media coverage are contributing to a higher level of public awareness in the country. Moreover, the training of medical professionals to administer ketamine therapy safely is leading to an increase in the number of clinics offering these services, improving accessibility for patients. In line with this, some insurance providers in the US are starting to cover ketamine therapy for certain conditions. This development is making the treatment more affordable and accessible to a broader patient population in the country.

Ask Analyst for 10% free customized report: https://www.imarcgroup.com/request?type=report&id=8356&flag=C

What Is Included In Market Segmentation?

The report has segmented the market into the following categories:

Breakup by Treatment:
• Depression
• Anxiety
• PTSD
• Others

Breakup by Therapy:
• On-Site Therapy
• Online Therapy

Breakup by Region:
• Northeast
• Midwest
• South
• West

The report provides a comprehensive analysis of the industry key players listed below:
• Better U LLC
• Field Trip Health and Wellness Ltd.
• Innerwell
• Ketamine Clinics Los Angeles
• Klarisana - Ketamine Treatment Austin
• Klarity Clinic
• Mindbloom Inc.
• Nue Life Health PBC
• NY Ketamine Infusions
• Vitalitas Denver

Related Reports:
Blockchain Supply Chain Market: https://www.digitaljournal.com/pr/news/imarc/blockchain-supply-chain-market-size-industry-share-growth-analysis-and-report-2024-2032

Wood Vinegar Market: https://www.digitaljournal.com/pr/news/imarc/wood-vinegar-market-size-global-share-price-trends-and-forecast-2024-2032

Medical Flexible Packaging Market: https://www.digitaljournal.com/pr/news/imarc/medical-flexible-packaging-market-size-global-share-industry-trends-and-outlook-2024-2032

Indonesia Frozen Food Market: https://www.digitaljournal.com/pr/news/imarc/indonesia-frozen-food-market-size-industry-share-growing-demand-and-overview-2024-2032

Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release U.S. Ketamine Clinics Market Size, Growing Demand, Trends Analysis and Forecast Report 2023-2028 here

News-ID: 3291035 • Views:

More Releases from IMARC Group

Vietnam Water Treatment Chemicals Market Share, Demand, Industry Growth And Forecast 2024-2032
Vietnam Water Treatment Chemicals Market Share, Demand, Industry Growth And Fore …
IMARC Group's report titled "Vietnam Water Treatment Chemicals Market Report by Type (Coagulants and Flocculants, Corrosion Inhibitors, Scale Inhibitors, Biocides and Disinfectants, Chelating Agents, Anti-Foaming Agents, PH Adjusters and Stabilizers, and Others), End User (Municipal, Power, Oil and Gas, Mining, Chemicals, Food and Beverage, Pulp and Paper, and Others), and Region 2024-2032" Vietnam water treatment chemicals market is projected to exhibit a growth rate (CAGR) of 4.99% during 2024-2032. The Vietnam water
Furniture Market Size, Sales Revenue, Industry Growth, Forecast 2024-2032
Furniture Market Size, Sales Revenue, Industry Growth, Forecast 2024-2032
IMARC Group, a leading market research company, has recently releases report titled "Furniture Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032" The global furniture market size reached US$ 660.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 701.7 Billion by 2032. Request For Sample Copy of Report For More Detailed Market insight: https://www.imarcgroup.com/furniture-market/requestsample Factors Affecting the Growth of the Furniture Industry: Rapid Urbanization: Urban areas are leading
Nanofibers Market Size, Share, and Report 2024-2032
Nanofibers Market Size, Share, and Report 2024-2032
According to IMARC Group latest report titled "Nanofibers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032", offers a comprehensive analysis of the industry, which comprises insights on nanofibers market. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global nanofibers market size reached US$ 1,591.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 9,948.5 Million by
Oxygen Concentrator Manufacturing Plant Report 2024: Business Plan, Capital Investments and Expenses
Oxygen Concentrator Manufacturing Plant Report 2024: Business Plan, Capital Inve …
IMARC Group's report, titled "Oxygen Concentrator Manufacturing Plant Project Report 2024: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue," provides a complete roadmap for setting up an oxygen concentrator manufacturing plant. The report covers various aspects, ranging from a broad market overview to intricate details like unit operations, raw material and utility requirements, infrastructure necessities, machinery requirements, manpower needs, packaging and transportation requirements, and more. In addition

All 5 Releases


More Releases for Ketamine

Ketamine Market 2022 Emerging Players, Growth Analysis and Precise Outlook | Seq …
The Global Ketamine Market report focuses on a comprehensive analysis of the recent and future prospects of the Ketamine industry. An in-depth analysis of historical trends, future trends, SWOT analysis, demographics, industrial advances, and regulatory requirements for the market has been performed to analyze the growth rate of each segment and sub-segment. The growth of the Ketamine market was essentially driven by the increasing R&D spending across the world. The
07-14-2021 | Health & Medicine
Fact.MR
Rising Demographic Trends In Elderly Population Boost Injectable Ketamine Market …
The Recent study by Fact.MR- (leading business and competitive intelligence provider) On global Injectable Ketamine market Survey study presents an all in all compilation of the historical, current and future outlook of Injectable Ketamine market as well as the factors responsible for such a Injectable Ketamine Market growth. The report on the market survey of Injectable Ketamine gives estimations of the Size of Injectable Ketamine Market and the overall share of
U.S. Psychedelic Drugs Market 2021| Industry Size, Share, Demand, Manufacturers …
U.S. Psychedelic Drugs Market research analysis report starts with a basic introduction of the 2021 market segmentation, future scenario, Industry growth rate, and industrial opportunities to 2028. The company profile section has parameters such as company synopsis, commercial synopsis, work strategy and planning, SWOT analysis, and present developments. With the study of competitor analysis, the Industry can get the know-how of the strategies of key players in the market that
Psychedelic Drugs Market By top key Players are Phencyclidine, Gamma Hydroxybuty …
One of the utmost and quickest ways to collect information for the business in this fast-paced industry is Psychedelic Drugs Market research or secondary research. This Psychedelic Drugs Market research report makes available state-of-the-art information about the entire market along with the holistic view of the market. It also assesses the Psychedelic Drugs Market status, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors
Increasing Trend of Onsite Clinic Market 2019 Trend and Forecast with Top Player …
Onsite Clinic Market: Employers are looking for ways to reduce their associated costs while maintaining a healthy workforce, and field clinics are a useful resource for managing chronic diseases and promoting good health. On-site health clinics are evolving to address these and other challenges faced by employers seeking to support a healthy workforce while reducing health care costs. According to a 2015 survey by Benefits Consultant Mercer, nearly 30% of companies
New Detailed Review of Oral Ketamine for Depression Published in JCP
Memphis, TN (April 16, 2019) – A review article published today in The Journal of Clinical Psychiatry indicates that orally administered ketamine is efficacious for depression but may take longer to yield results. The review, authored by Joshua D. Rosenblat and colleagues at the University of Toronto, analyzed 13 articles, including 2 randomized controlled trials (RCTs). The RCTs demonstrated antidepressant efficacy and good tolerability for oral ketamine, but significant changes